SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-066048
Filing Date
2023-05-30
Accepted
2023-05-30 16:18:11
Documents
12
Period of Report
2023-05-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2317177d1_8k.htm   iXBRL 8-K 41094
  Complete submission text file 0001104659-23-066048.txt   220650

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adap-20230530.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20230530_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20230530_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2317177d1_8k_htm.xml XML 3686
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 23976661
SIC: 2836 Biological Products, (No Diagnostic Substances)